<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37068113</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>03</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>29</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1549-1676</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Apr</Month></PubDate></JournalIssue><Title>PLoS medicine</Title><ISOAbbreviation>PLoS Med</ISOAbbreviation></Journal><ArticleTitle>Prevalence and characteristics of long COVID in elderly patients: An observational cohort study of over 2 million adults in the US.</ArticleTitle><Pagination><StartPage>e1004194</StartPage><MedlinePgn>e1004194</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e1004194</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pmed.1004194</ELocationID><Abstract><AbstractText Label="BACKGROUND">Incidence of long COVID in the elderly is difficult to estimate and can be underreported. While long COVID is sometimes considered a novel disease, many viral or bacterial infections have been known to cause prolonged illnesses. We postulate that some influenza patients might develop residual symptoms that would satisfy the diagnostic criteria for long COVID, a condition we call "long Flu." In this study, we estimate the incidence of long COVID and long Flu among Medicare patients using the World Health Organization (WHO) consensus definition. We compare the incidence, symptomatology, and healthcare utilization between long COVID and long Flu patients.</AbstractText><AbstractText Label="METHODS AND FINDINGS">This is a cohort study of Medicare (the US federal health insurance program) beneficiaries over 65. ICD-10-CM codes were used to capture COVID-19, influenza, and residual symptoms. Long COVID was identified by (a) the designated long COVID code B94.8 (code-based definition), or (b) any of 11 symptoms identified in the WHO definition (symptom-based definition), from 1 to 3 months post-infection. A symptom would be excluded if it occurred in the year prior to infection. Long Flu was identified in influenza patients from the combined 2018 and 2019 Flu seasons by the same symptom-based definition for long COVID. Long COVID and long Flu were compared in 4 outcome measures: (a) hospitalization (any cause); (b) hospitalization (for long COVID symptom); (c) emergency department (ED) visit (for long COVID symptom); and (d) number of outpatient encounters (for long COVID symptom), adjusted for age, sex, race, region, Medicare-Medicaid dual eligibility status, prior-year hospitalization, and chronic comorbidities. Among 2,071,532 COVID-19 patients diagnosed between April 2020 and June 2021, symptom-based definition identified long COVID in 16.6% (246,154/1,479,183) and 29.2% (61,631/210,765) of outpatients and inpatients, respectively. The designated code gave much lower estimates (outpatients 0.49% (7,213/1,479,183), inpatients 2.6% (5,521/210,765)). Among 933,877 influenza patients, 17.0% (138,951/817,336) of outpatients and 24.6% (18,824/76,390) of inpatients fit the long Flu definition. Long COVID patients had higher incidence of dyspnea, fatigue, palpitations, loss of taste/smell, and neurocognitive symptoms compared to long Flu. Long COVID outpatients were more likely to have any-cause hospitalization (31.9% (74,854/234,688) versus 26.8% (33,140/123,736), odds ratio 1.06 (95% CI 1.05 to 1.08, p &lt; 0.001)), and more outpatient visits than long Flu outpatients (mean 2.9(SD 3.4) versus 2.5(SD 2.7) visits, incidence rate ratio 1.09 (95% CI 1.08 to 1.10, p &lt; 0.001)). There were less ED visits in long COVID patients, probably because of reduction in ED usage during the pandemic. The main limitation of our study is that the diagnosis of long COVID in is not independently verified.</AbstractText><AbstractText Label="CONCLUSIONS">Relying on specific long COVID diagnostic codes results in significant underreporting. We observed that about 30% of hospitalized COVID-19 patients developed long COVID. In a similar proportion of patients, long COVID-like symptoms (long Flu) can be observed after influenza, but there are notable differences in symptomatology between long COVID and long Flu. The impact of long COVID on healthcare utilization is higher than long Flu.</AbstractText><CopyrightInformation>Copyright: This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fung</LastName><ForeName>Kin Wah</ForeName><Initials>KW</Initials><Identifier Source="ORCID">0000-0003-0593-5377</Identifier><AffiliationInfo><Affiliation>Lister Hill National Center for Biomedical Communications, National Library of Medicine, National Institutes of Health, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baye</LastName><ForeName>Fitsum</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Lister Hill National Center for Biomedical Communications, National Library of Medicine, National Institutes of Health, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baik</LastName><ForeName>Seo H</ForeName><Initials>SH</Initials><Identifier Source="ORCID">0000-0002-2077-4316</Identifier><AffiliationInfo><Affiliation>Lister Hill National Center for Biomedical Communications, National Library of Medicine, National Institutes of Health, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Zhaonian</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Lister Hill National Center for Biomedical Communications, National Library of Medicine, National Institutes of Health, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McDonald</LastName><ForeName>Clement J</ForeName><Initials>CJ</Initials><Identifier Source="ORCID">0000-0002-0514-9539</Identifier><AffiliationInfo><Affiliation>Lister Hill National Center for Biomedical Communications, National Library of Medicine, National Institutes of Health, United States of America.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052060">Research Support, N.I.H., Intramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS Med</MedlineTA><NlmUniqueID>101231360</NlmUniqueID><ISSNLinking>1549-1277</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006278" MajorTopicYN="N">Medicare</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="Y">Influenza, Human</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>5</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>3</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>17</Day><Hour>13</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>4</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37068113</ArticleId><ArticleId IdType="pmc">PMC10150975</ArticleId><ArticleId IdType="doi">10.1371/journal.pmed.1004194</ArticleId><ArticleId IdType="pii">PMEDICINE-D-22-03023</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Al-Aly Z, Xie Y, Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021;594(7862):259&#x2013;264. Epub 2021/04/23. doi: 10.1038/s41586-021-03553-9 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03553-9</ArticleId><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Rio C, Collins LF, Malani P. Long-term Health Consequences of COVID-19. JAMA. 2020;324(17):1723&#x2013;1724. Epub 2020/10/09. doi: 10.1001/jama.2020.19719 ; PubMed Central PMCID: PMC8019677.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.19719</ArticleId><ArticleId IdType="pmc">PMC8019677</ArticleId><ArticleId IdType="pubmed">33031513</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al.. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220&#x2013;232. Epub 2021/01/12. doi: 10.1016/S0140-6736(20)32656-8 ; PubMed Central PMCID: PMC7833295.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021;8(5):416&#x2013;427. Epub 2021/04/10. doi: 10.1016/S2215-0366(21)00084-5 ; PubMed Central PMCID: PMC8023694 no competing interests.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(21)00084-5</ArticleId><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>Wanga V, Chevinsky JR, Dimitrov LV, Gerdes ME, Whitfield GP, Bonacci RA, et al.. Long-Term Symptoms Among Adults Tested for SARS-CoV-2&#x2014;United States, January 2020-April 2021. MMWR Morb Mortal Wkly Rep. 2021;70(36):1235&#x2013;1241. Epub 2021/09/10. doi: 10.15585/mmwr.mm7036a1 ; PubMed Central PMCID: PMC8437054 Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7036a1</ArticleId><ArticleId IdType="pmc">PMC8437054</ArticleId><ArticleId IdType="pubmed">34499626</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, et al.. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. 2021;11(1):16144. Epub 2021/08/11. doi: 10.1038/s41598-021-95565-8 ; PubMed Central PMCID: PMC8352980.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Carfi A, Bernabei R, Landi F, Gemelli Against C-P-ACSG. Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020;324(6):603&#x2013;605. Epub 2020/07/10. doi: 10.1001/jama.2020.12603 ; PubMed Central PMCID: PMC7349096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabrera Martimbianco AL, Pacheco RL, Bagattini AM, Riera R. Frequency, signs and symptoms, and criteria adopted for long COVID-19: A systematic review. Int J Clin Pract. 2021;75(10):e14357. Epub 2021/05/13. doi: 10.1111/ijcp.14357 ; PubMed Central PMCID: PMC8236920.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijcp.14357</ArticleId><ArticleId IdType="pmc">PMC8236920</ArticleId><ArticleId IdType="pubmed">33977626</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmad MS, Shaik RA, Ahmad RK, Yusuf M, Khan M, Almutairi AB, et al.. "LONG COVID": an insight. Eur Rev Med Pharmacol Sci. 2021;25(17):5561&#x2013;5577. Epub 2021/09/18. doi: 10.26355/eurrev_202109_26669 .</Citation><ArticleIdList><ArticleId IdType="doi">10.26355/eurrev_202109_26669</ArticleId><ArticleId IdType="pubmed">34533807</ArticleId></ArticleIdList></Reference><Reference><Citation>Akbarialiabad H, Taghrir MH, Abdollahi A, Ghahramani N, Kumar M, Paydar S, et al.. Long COVID, a comprehensive systematic scoping review. Infection. 2021;49(6):1163&#x2013;1186. Epub 2021/07/29. doi: 10.1007/s15010-021-01666-x ; PubMed Central PMCID: PMC8317481.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-021-01666-x</ArticleId><ArticleId IdType="pmc">PMC8317481</ArticleId><ArticleId IdType="pubmed">34319569</ArticleId></ArticleIdList></Reference><Reference><Citation>Groff D, Sun A, Ssentongo AE, Ba DM, Parsons N, Poudel GR, et al.. Short-term and Long-term Rates of Postacute Sequelae of SARS-CoV-2 Infection: A Systematic Review. JAMA Netw Open. 2021;4(10):e2128568. Epub 2021/10/14. doi: 10.1001/jamanetworkopen.2021.28568 ; PubMed Central PMCID: PMC8515212.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.28568</ArticleId><ArticleId IdType="pmc">PMC8515212</ArticleId><ArticleId IdType="pubmed">34643720</ArticleId></ArticleIdList></Reference><Reference><Citation>Rando HM, Bennett TD, Byrd JB, Bramante C, Callahan TJ, Chute CG, et al.. Challenges in defining Long COVID: Striking differences across literature, Electronic Health Records, and patient-reported information. medRxiv. 2021. Epub 2021/04/02. doi: 10.1101/2021.03.20.21253896 ; PubMed Central PMCID: PMC8010765.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.03.20.21253896</ArticleId><ArticleId IdType="pmc">PMC8010765</ArticleId><ArticleId IdType="pubmed">33791733</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y, Pinto MD, Borelli JL, Mehrabadi MA, Abrihim H, Dutt N, et al.. COVID Symptoms, Symptom Clusters, and Predictors for Becoming a Long-Hauler: Looking for Clarity in the Haze of the Pandemic. medRxiv. 2021. Epub 2021/03/11. doi: 10.1101/2021.03.03.21252086 ; PubMed Central PMCID: PMC7941647.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.03.03.21252086</ArticleId><ArticleId IdType="pmc">PMC9510954</ArticleId><ArticleId IdType="pubmed">36154716</ArticleId></ArticleIdList></Reference><Reference><Citation>Writing Committee for the CSG, Morin L, Savale L, Pham T, Colle R, Figueiredo S, et al.. Four-Month Clinical Status of a Cohort of Patients After Hospitalization for COVID-19. JAMA. 2021;325(15):1525&#x2013;1534. Epub 2021/03/18. doi: 10.1001/jama.2021.3331 ; PubMed Central PMCID: PMC7970386.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.3331</ArticleId><ArticleId IdType="pmc">PMC7970386</ArticleId><ArticleId IdType="pubmed">33729425</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirschtick JL, Titus AR, Slocum E, Power LE, Hirschtick RE, Elliott MR, et al.. Population-Based Estimates of Post-acute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (PASC) Prevalence and Characteristics. Clin Infect Dis. 2021;73(11):2055&#x2013;2064. Epub 2021/05/20. doi: 10.1093/cid/ciab408 ; PubMed Central PMCID: PMC8240848.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab408</ArticleId><ArticleId IdType="pmc">PMC8240848</ArticleId><ArticleId IdType="pubmed">34007978</ArticleId></ArticleIdList></Reference><Reference><Citation>Lund LC, Hallas J, Nielsen H, Koch A, Mogensen SH, Brun NC, et al.. Post-acute effects of SARS-CoV-2 infection in individuals not requiring hospital admission: a Danish population-based cohort study. Lancet Infect Dis. 2021;21(10):1373&#x2013;1382. Epub 2021/05/14. doi: 10.1016/S1473-3099(21)00211-5 ; PubMed Central PMCID: PMC8110209 participation in research projects funded by Alcon, Almirall, Astellas, AstraZeneca, Boehringer Ingelheim, Novo Nordisk, Servier, and LEO Pharma, outside the the current work. LCL reports funds paid to his institution for participation in research projects funded by Menarini Pharmaceuticals and LEO Pharma, outside the current work. HN reports funds paid to their institution for participation in research projects funded by Merck Sharp &amp; Dohme and Novo Nordisk Foundation, outside the current work. The institution of CFC and RWT is involved in studies with funding from various companies as research grants to (and administered by) Aarhus University, outside the current work. AK, SHM, and NCB report no competing interests.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00211-5</ArticleId><ArticleId IdType="pmc">PMC8110209</ArticleId><ArticleId IdType="pubmed">33984263</ArticleId></ArticleIdList></Reference><Reference><Citation>Yomogida K, Zhu S, Rubino F, Figueroa W, Balanji N, Holman E. Post-Acute Sequelae of SARS-CoV-2 Infection Among Adults Aged &gt;/ = 18 Years&#x2014;Long Beach, California, April 1-December 10, 2020. MMWR Morb Mortal Wkly Rep. 2021;70(37):1274&#x2013;1277. Epub 2021/09/17. doi: 10.15585/mmwr.mm7037a2 ; PubMed Central PMCID: PMC8445372 Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7037a2</ArticleId><ArticleId IdType="pmc">PMC8445372</ArticleId><ArticleId IdType="pubmed">34529639</ArticleId></ArticleIdList></Reference><Reference><Citation>Logue JK, Franko NM, McCulloch DJ, McDonald D, Magedson A, Wolf CR, et al.. Sequelae in Adults at 6 Months After COVID-19 Infection. JAMA Netw Open. 2021;4(2):e210830. Epub 2021/02/20. doi: 10.1001/jamanetworkopen.2021.0830 ; PubMed Central PMCID: PMC7896197.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.0830</ArticleId><ArticleId IdType="pmc">PMC7896197</ArticleId><ArticleId IdType="pubmed">33606031</ArticleId></ArticleIdList></Reference><Reference><Citation>UK Office for National Statistics. Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK.
Sept
2021.  dataset. Available from: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/datasets/alldatarelatingtoprevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk.</Citation></Reference><Reference><Citation>U.S. Government Accountability Office. Science &amp; Tech Spotlight: Long COVID. Available from: https://www.gao.gov/products/gao-22-105666?utm_source=onepager&amp;utm_medium=email&amp;utm_campaign=email_staa.</Citation></Reference><Reference><Citation>Tenforde MW, Devine OJ, Reese HE, Silk BJ, Iuliano AD, Threlkel R, et al.. Point Prevalence Estimates of Activity-Limiting Long-Term Symptoms among U.S. Adults &gt;/ = 1 Month After Reported SARS-CoV-2 Infection, November 1, 2021. J Infect Dis. 2022. Epub 2022/07/02. doi: 10.1093/infdis/jiac281 ; PubMed Central PMCID: PMC9278232.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac281</ArticleId><ArticleId IdType="pmc">PMC9278232</ArticleId><ArticleId IdType="pubmed">35776165</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, et al.. Attributes and predictors of long COVID. Nat Med. 2021;27(4):626&#x2013;631. Epub 2021/03/12. doi: 10.1038/s41591-021-01292-y ; PubMed Central PMCID: PMC7611399.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendelson M, Nel J, Blumberg L, Madhi SA, Dryden M, Stevens W, et al.. Long-COVID: An evolving problem with an extensive impact. S Afr Med J. 2020;111(1):10&#x2013;12. Epub 2021/01/07. doi: 10.7196/SAMJ.2020.v111i11.15433 .</Citation><ArticleIdList><ArticleId IdType="doi">10.7196/SAMJ.2020.v111i11.15433</ArticleId><ArticleId IdType="pubmed">33403997</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham J. &#x2018;That&#x2019;s Just Part of Aging&#x2019;: Long Covid Symptoms Are Often Overlooked in Seniors. Kaiser Health News. Available from: https://khn.org/news/article/long-covid-symptoms-seniors/.</Citation></Reference><Reference><Citation>Cohen K, Ren S, Heath K, Dasmarinas MC, Jubilo KG, Guo Y, et al.. Risk of persistent and new clinical sequelae among adults aged 65 years and older during the post-acute phase of SARS-CoV-2 infection: retrospective cohort study. BMJ. 2022;376:e068414. Epub 2022/02/11. doi: 10.1136/bmj-2021-068414 ; PubMed Central PMCID: PMC8828141 at www.icmje.org/coi_disclosure.pdf and declare: support from Optum Laboratories for the submitted work; no financial relationships with any organizations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work. KC declares consulting from Pfizer. ML declares honoraria/consulting from Merck, Sanofi-Pasteur, Bristol Myers-Squibb, and Antigen Discovery; research funding (institutional) from Pfizer; and unpaid scientific advisory services to Janssen, Astra-Zeneca, One Day Sooner, and Covaxx (United Biomedical).</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-068414</ArticleId><ArticleId IdType="pmc">PMC8828141</ArticleId><ArticleId IdType="pubmed">35140117</ArticleId></ArticleIdList></Reference><Reference><Citation>Walle-Hansen MM, Ranhoff AH, Mellingsaeter M, Wang-Hansen MS, Myrstad M. Health-related quality of life, functional decline, and long-term mortality in older patients following hospitalisation due to COVID-19. BMC Geriatr. 2021;21(1):199. Epub 2021/03/24. doi: 10.1186/s12877-021-02140-x ; PubMed Central PMCID: PMC7983098.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12877-021-02140-x</ArticleId><ArticleId IdType="pmc">PMC7983098</ArticleId><ArticleId IdType="pubmed">33752614</ArticleId></ArticleIdList></Reference><Reference><Citation>Bannister BA. Post-infectious disease syndrome. Postgrad Med J. 1988;64(753):559&#x2013;567. Epub 1988/07/01. doi: 10.1136/pgmj.64.753.559 ; PubMed Central PMCID: PMC2428896.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/pgmj.64.753.559</ArticleId><ArticleId IdType="pmc">PMC2428896</ArticleId><ArticleId IdType="pubmed">3074289</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal AD, VanElzakker MB. Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms. Front Microbiol. 2021;12:698169. Epub 2021/07/13. doi: 10.3389/fmicb.2021.698169 ; PubMed Central PMCID: PMC8260991.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.698169</ArticleId><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Honigsbaum M, Krishnan L. Taking pandemic sequelae seriously: from the Russian influenza to COVID-19 long-haulers. Lancet. 2020;396(10260):1389&#x2013;1391. Epub 2020/10/16. doi: 10.1016/S0140-6736(20)32134-6 ; PubMed Central PMCID: PMC7550169.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32134-6</ArticleId><ArticleId IdType="pmc">PMC7550169</ArticleId><ArticleId IdType="pubmed">33058777</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed H, Patel K, Greenwood DC, Halpin S, Lewthwaite P, Salawu A, et al.. Long-term clinical outcomes in survivors of severe acute respiratory syndrome and Middle East respiratory syndrome coronavirus outbreaks after hospitalisation or ICU admission: A systematic review and meta-analysis. J Rehabil Med. 2020;52(5):jrm00063. Epub 2020/05/26. doi: 10.2340/16501977-2694 .</Citation><ArticleIdList><ArticleId IdType="doi">10.2340/16501977-2694</ArticleId><ArticleId IdType="pubmed">32449782</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J, Wu J, Hao S, Yang M, Lu X, Chen X, et al.. Long term outcomes in survivors of epidemic Influenza A (H7N9) virus infection. Sci Rep. 2017;7(1):17275. Epub 2017/12/10. doi: 10.1038/s41598-017-17497-6 ; PubMed Central PMCID: PMC5722861.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-17497-6</ArticleId><ArticleId IdType="pmc">PMC5722861</ArticleId><ArticleId IdType="pubmed">29222500</ArticleId></ArticleIdList></Reference><Reference><Citation>Research Data Assistance Center (ResDAC). CMS Virtual Research Data Center (VRDC). Available from: https://www.resdac.org/cms-virtual-research-data-center-vrdc.</Citation></Reference><Reference><Citation>Kaiser Family Foundation. A Primer on Medicare&#x2014;Key facts about the Medicare program and the people it covers. Available from: https://files.kff.org/attachment/report-a-primer-on-medicare-key-facts-about-the-medicare-program-and-the-people-it-covers.</Citation></Reference><Reference><Citation>Administration on Aging&#x2014;U.S. Department of Health and Human Services. 2018.  Profile of Older Americans. Available from: https://acl.gov/aging-and-disability-in-america/data-and-research/profile-older-americans.</Citation></Reference><Reference><Citation>World Health Organization. A clinical case definition of post COVID-19 condition by a Delphi consensus. Available from: http://www.fx1234.com/iris/bitstream/handle/10665/345824/WHO-2019-nCoV-Post-COVID-19-condition-Clinical-case-definition-2021.1-eng.pdf?sequence=1&amp;isAllowed=y.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Amenta EM, Spallone A, Rodriguez-Barradas MC, El Sahly HM, Atmar RL, Kulkarni PA. Postacute COVID-19: An Overview and Approach to Classification. Open Forum Infect Dis. 2020;7(12):ofaa509. Epub 2021/01/07. doi: 10.1093/ofid/ofaa509 ; PubMed Central PMCID: PMC7665635.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofaa509</ArticleId><ArticleId IdType="pmc">PMC7665635</ArticleId><ArticleId IdType="pubmed">33403218</ArticleId></ArticleIdList></Reference><Reference><Citation>Center for Medicare Advocacy. Expanded Medicare Skilled Nursing Facility Coverage During the Covid-19 Pandemic. Available from: https://medicareadvocacy.org/snf-limitations-waived-during-covid/.</Citation></Reference><Reference><Citation>Centers for Medicare &amp; Medicaid Services. Chronic Conditions Data Warehouse: CCW Chronic Condition Algorithms. Available from: https://www.ccwdata.org/web/guest/condition-categories.</Citation></Reference><Reference><Citation>Charlson ME, Charlson RE, Peterson JC, Marinopoulos SS, Briggs WM, Hollenberg JP. The Charlson comorbidity index is adapted to predict costs of chronic disease in primary care patients. J Clin Epidemiol. 2008;61(12):1234&#x2013;1240. Epub 2008/07/16. doi: 10.1016/j.jclinepi.2008.01.006 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2008.01.006</ArticleId><ArticleId IdType="pubmed">18619805</ArticleId></ArticleIdList></Reference><Reference><Citation>Agresti A, Kateri M. Categorical Data Analysis. 2011. p. 206&#x2013;8.</Citation></Reference><Reference><Citation>Chen S-Y, Feng Z, Yi X. A general introduction to adjustment for multiple comparisons. Journal of Thoracic Disease. 2017;9(6):1725&#x2013;1729. doi: 10.21037/jtd.2017.05.34</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/jtd.2017.05.34</ArticleId><ArticleId IdType="pmc">PMC5506159</ArticleId><ArticleId IdType="pubmed">28740688</ArticleId></ArticleIdList></Reference><Reference><Citation>Berkson J. Application of the Logistic Function to Bio-Assay. J Am Stat Assoc. 1944;39(227):357&#x2013;365. doi: 10.2307/2280041</Citation><ArticleIdList><ArticleId IdType="doi">10.2307/2280041</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubin DB. Using Propensity Scores to Help Design Observational Studies: Application to the Tobacco Litigation. Health Serv Outcome Res Methodol. 2001;2(3):169&#x2013;188. doi: 10.1023/A:1020363010465</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/A</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Mahoney LL, Routen A, Gillies C, Ekezie W, Welford A, Zhang A, et al.. The prevalence and long-term health effects of Long Covid among hospitalised and non-hospitalised populations: A systematic review and meta-analysis. EClinicalMedicine. 2023;55:101762. Epub 2022/12/08. doi: 10.1016/j.eclinm.2022.101762 ; PubMed Central PMCID: PMC9714474.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101762</ArticleId><ArticleId IdType="pmc">PMC9714474</ArticleId><ArticleId IdType="pubmed">36474804</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfaff ER, Girvin AT, Bennett TD, Bhatia A, Brooks IM, Deer RR, et al.. Identifying who has long COVID in the USA: a machine learning approach using N3C data. Lancet Digit Health. 2022;4(7):e532&#x2013;e541. doi: 10.1016/S2589-7500(22)00048-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2589-7500(22)00048-6</ArticleId><ArticleId IdType="pmc">PMC9110014</ArticleId><ArticleId IdType="pubmed">35589549</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker AJ, MacKenna B, Inglesby P, Tomlinson L, Rentsch CT, Curtis HJ, et al.. Clinical coding of long COVID in English primary care: a federated analysis of 58 million patient records in situ using OpenSAFELY. Br J Gen Pract. 2021;71(712):e806&#x2013;e814. doi: 10.3399/BJGP.2021.0301</Citation><ArticleIdList><ArticleId IdType="doi">10.3399/BJGP.2021.0301</ArticleId><ArticleId IdType="pmc">PMC8340730</ArticleId><ArticleId IdType="pubmed">34340970</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfaff ER, Madlock-Brown C, Baratta JM, Bhatia A, Davis H, Girvin A, et al.. Coding Long COVID: Characterizing a new disease through an ICD-10 lens. medRxiv. 2022:2022.04.18.22273968. doi: 10.1101/2022.04.18.22273968</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.04.18.22273968</ArticleId><ArticleId IdType="pmc">PMC9931566</ArticleId><ArticleId IdType="pubmed">36793086</ArticleId></ArticleIdList></Reference><Reference><Citation>Maltezou HC, Pavli A, Tsakris A. Post-COVID Syndrome: An Insight on Its Pathogenesis. Vaccines (Basel). 2021;9(5). Epub 2021/06/03. doi: 10.3390/vaccines9050497 ; PubMed Central PMCID: PMC8151752.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines9050497</ArticleId><ArticleId IdType="pmc">PMC8151752</ArticleId><ArticleId IdType="pubmed">34066007</ArticleId></ArticleIdList></Reference><Reference><Citation>Song E, Zhang C, Israelow B, Lu-Culligan A, Prado AV, Skriabine S, et al.. Neuroinvasion of SARS-CoV-2 in human and mouse brain. bioRxiv. 2020:2020.06.25.169946. doi: 10.1101/2020.06.25.169946</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.06.25.169946</ArticleId><ArticleId IdType="pmc">PMC7808299</ArticleId><ArticleId IdType="pubmed">33433624</ArticleId></ArticleIdList></Reference><Reference><Citation>Ritchie K, Chan D, Watermeyer T. The cognitive consequences of the COVID-19 epidemic: collateral damage? Brain. Communications. 2020;2(2). doi: 10.1093/braincomms/fcaa069</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcaa069</ArticleId><ArticleId IdType="pmc">PMC7314157</ArticleId><ArticleId IdType="pubmed">33074266</ArticleId></ArticleIdList></Reference><Reference><Citation>Bikdeli B, Madhavan MV, Jimenez D, Chuich T, Dreyfus I, Driggin E, et al.. COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020;75(23):2950&#x2013;2973. Epub 2020/04/21. doi: 10.1016/j.jacc.2020.04.031 ; PubMed Central PMCID: PMC7164881.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.04.031</ArticleId><ArticleId IdType="pmc">PMC7164881</ArticleId><ArticleId IdType="pubmed">32311448</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Xiao M, Zhang S, Xia P, Cao W, Jiang W, et al.. Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19. N Engl J Med. 2020;382(17):e38. Epub 2020/04/09. doi: 10.1056/NEJMc2007575 ; PubMed Central PMCID: PMC7161262.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2007575</ArticleId><ArticleId IdType="pmc">PMC7161262</ArticleId><ArticleId IdType="pubmed">32268022</ArticleId></ArticleIdList></Reference><Reference><Citation>Guler SA, Ebner L, Aubry-Beigelman C, Bridevaux P-O, Brutsche M, Clarenbach C, et al.. Pulmonary function and radiological features 4 months after COVID-19: first results from the national prospective observational Swiss COVID-19 lung study. Eur Respir J. 2021;57(4):2003690. doi: 10.1183/13993003.03690-2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.03690-2020</ArticleId><ArticleId IdType="pmc">PMC8082329</ArticleId><ArticleId IdType="pubmed">33419891</ArticleId></ArticleIdList></Reference><Reference><Citation>Fung KW, Baik SH, Baye F, Zheng Z, Huser V, McDonald CJ. Effect of common maintenance drugs on the risk and severity of COVID-19 in elderly patients. PLoS ONE. 2022;17(4):e0266922. Epub 2022/04/19. doi: 10.1371/journal.pone.0266922 ; PubMed Central PMCID: PMC9015134.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0266922</ArticleId><ArticleId IdType="pmc">PMC9015134</ArticleId><ArticleId IdType="pubmed">35436293</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>